Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
Neoantigens determine anti-cancer immunoreactivity and are important functional targets for immunotherapy. Here, the authors use deep mass spectrometry to characterize neoepitopes from human melanoma tissue and show the presence of tumour-reactive T cells with specificity for selected neoantigens.
Guardado en:
Autores principales: | Michal Bassani-Sternberg, Eva Bräunlein, Richard Klar, Thomas Engleitner, Pavel Sinitcyn, Stefan Audehm, Melanie Straub, Julia Weber, Julia Slotta-Huspenina, Katja Specht, Marc E. Martignoni, Angelika Werner, Rüdiger Hein, Dirk H. Busch, Christian Peschel, Roland Rad, Jürgen Cox, Matthias Mann, Angela M. Krackhardt |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9d43ba6c8b234b1ab6f92d398fb3a892 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pan-cancer analysis of neoepitopes
por: Gabriel N. Teku, et al.
Publicado: (2018) -
Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope
por: Hakimeh Ebrahimi-Nik, et al.
Publicado: (2021) -
Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
por: Huahui Yu, et al.
Publicado: (2021) -
APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy
por: Christopher B. Driscoll, et al.
Publicado: (2020) -
Deep learning boosts sensitivity of mass spectrometry-based immunopeptidomics
por: Mathias Wilhelm, et al.
Publicado: (2021)